News
Eli Lilly's Mounjaro (Tirzepatide), a dual GIP and GLP-1 receptor agonist, has launched in India, generating buzz as a weight ...
A once-weekly dose of tirzepatide (Mounjaro) can lead to significant, sustained weight loss for up to 3 years in adults with ...
Researchers at Mass General Brigham found that by December 2023, over one-third of all new prescriptions for type 2 diabetes ...
7don MSN
Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...
Meghan Trainor said she’s been taking Mounjaro for weight loss alongside her husband, ‘Spy Kids’ actor Daryl Sabara. The ...
A MUM has revealed the surprising side benefit of using skinny jabs – and it’s proved just as life-changing as shedding 7st. Emma Clark, from Hamilton, Lanarkshire, started using ...
Tirzepatide (Mounjaro) launched in India in March 2025, promising new hope for diabetes and obesity treatment. An expert ...
Eli Lilly's Mounjaro enters Indian market, triggering a sharp rise in consultations as obesity rates climb and patients seek more accessible treatment options ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results